Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Novel vaccine protects against RSV
calf
The vaccine was used to immunise five calves aged three-to-six weeks, via two injections four weeks apart. (stock photo)
Success with cattle offers hope for human vaccine
 
A novel vaccine has shown success in protecting cattle from respiratory syncytial virus (RSV) infection, and could offer hope for a human vaccine, researchers say.

RSV causes the majority of respiratory disease in cattle and is responsible for substantial economic loss. In humans, it causes serious bronchiolitis and pneumonia in young children, the elderly and people with compromised immune systems. There are estimated to be more than 250,000 human deaths a year as a result of RSV infection.

Currently there is no licensed vaccine for humans and cattle vaccines have noted issues with safety and effectiveness.

Research on the novel vaccine was conducted by a team of experts from the National Institute of Allergy and Infectious Diseases (NIAID) in the US, the Pirbright Institute in the UK and the Institute for Research in Biomedicine in Switzerland.

The vaccine was used to immunise five calves aged three-to-six weeks, via two injections four weeks apart. It contains a single, structurally engineered RSV protein, which is a stabilised version of the RSV fusion (F) glycoprotein it its initial conformation, pre-F. Other vaccines have used the same protein in its final conformation, post-F, but scientists say the immune response is much lower.

A second group of five calves were injected with a post-F protein, while the third group received two placebo injections of saline.

Four weeks later, calves in all three groups were infected with RSV. Of those injected with pre-F, four out of five were protected from RSV viral replication in the upper and lower respiratory tract and calves had high levels of neutralising antibodies - more than 100 fold higher than those given the post-F vaccine. However, RSV was detected in all calves given the post-F vaccine or the placebo.

Researchers say their findings, which were published in npj Vaccines, support further work on pre-F vaccines to protect humans and cattle from RSV. NIAID recently started testing a similar vaccine in a phase one human trial.

Become a member or log in to add this story to your CPD history

HM The Queen opens new centre for elephant care

News Story 1
 HM The Queen, accompanied by HRH The Duke of Edinburgh, has officially unveiled ZSL Whipsnade Zoo’s brand new Centre for Elephant Care.

Set amidst 30 acres of rolling paddocks, the custom-designed Centre for Elephant Care is the new home for the Zoo’s herd of nine Asian elephants.

The Centre will provide more than 700m² of indoor space and contains an array of elephant-friendly features, including dimming lights to mimic night-time and one metre-deep soft sand flooring.  

News Shorts
New manual to help producers use medicines responsibly

A new manual to help sheep and beef producers use medicines responsibly has been published by AHDB Beef & Lamb.

The Better Returns Programme manual, Using Medicines Correctly for Better Returns, outlines the key principles when using medicines on the farm.

It includes making sure the medicine and correct dose is used at the right time, and that it is stored and administered correctly. It also explains the importance of using antibiotics and anthelmintics responsibly to avoid the build up of resistance.